Golimumab (Simponi) for Inflammatory Arthritis (vol 51, pg 55, 2009)

被引：0
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2009年 / 51卷 / 1317期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
[1]   Utilization Pattern of Golimumab (Simponi®) in Patients with Inflammatory Arthritis in Real-Life Clinical Practice in Canada [J].
Abbas, Amir ;
Monfared, Tahami .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 :41-41
[2]   Introduction (vol 55, pg 1, 2009) [J].
Baldwin, J. Timothy .
ASAIO JOURNAL, 2009, 55 (03) :307-307
[3]   Bolt (vol 19, pg 51, 2009) [J].
Silliphant, Stirling .
SIGHT AND SOUND, 2009, 19 (03) :96-96
[4]   Golimumab: A Review in Inflammatory Arthritis [J].
Frampton, James E. .
BIODRUGS, 2017, 31 (03) :263-274
[5]   Golimumab: A Review in Inflammatory Arthritis [J].
James E. Frampton .
BioDrugs, 2017, 31 :263-274
[6]   Cimzia (certolizumab pegol), Simponi (golimumab) The next generation of monoclonal antibody treatment for rheumatoid arthritis [J].
Nolan, Mark .
EJHP PRACTICE, 2010, 16 (06) :52-53
[7]   The constraints of terminology (vol 51, pg 87, 2009) [J].
Baxter, Peter .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2009, 51 (03) :247-247
[8]   Innovation and competition policy (vol 1, pg 55, 2009) [J].
Goto, A. .
JAPANESE ECONOMIC REVIEW, 2009, 60 (03) :405-405
[9]   When a Statin Fails (vol 51, pg 58, 2009) [J].
不详 .
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2009, 51 (1319) :68-68
[10]   Vancomycin Dosing and Monitoring (vol 51, pg 25, 2009) [J].
不详 .
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2009, 51 (1310) :32-32
12345